Genetic instabilities in human cancers
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Whether and how human tumours are genetically unstable has been debated for decades. There is now evidence that most cancers may indeed be genetically unstable, but that the instability exists at two distinct levels. In a small subset of tumours, the instability is observed at the nucleotide level and results in base substitutions or deletions or insertions of a few nucleotides. In most other cancers, the instability is observed at the chromosome level, resulting in losses and gains of whole chromosomes or large portions thereof. Recognition and comparison of these instabilities are leading to new insights into tumour pathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic defects such as DNA mismatch repair deficiencies (dMMR) and microsatellite instability (MSI) predispose tumor cells to the accumulation of somatic mutations and are associated with increased TMB (Lengauer et al., 1998) and increased susceptibility to ICB (Le et al., 2017).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Lengauer et al., 1998
Citations
Cites
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., & Kolodner, R. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,873
Clues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710
Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström-Lahti, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,276
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,114
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,039
Cited by
Items 301–400 of 1,009
Sumara, I., Quadroni, M., Frei, C., Olma, M. H., Sumara, G., Ricci, R., & Peter, M. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.03.019 · Cited by 229
CGH-Explorer: a program for analysis of array-CGH data
Lingjærde, O. C., Baumbusch, L. O., Liestøl, K., Glad, I. K., & Børresen-Dale, A.-L. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti113 · Cited by 230
“The detection and mapping of these genes is important for understanding cancer progression and for associating aberrations with cancer phenotypes (Lengauer et al., 1998).”
Regulating DNA Replication in Eukarya
Siddiqui, K., On, K. F., & Diffley, J. F. X. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012930 · Cited by 229
“2010), a phenomenon observed in many human cancers (Lengauer et al. 1998).”
BackgroundNon-targeted effects of ionising radiation—Implications for low dose risk
Kadhim, M., Salomaa, S., Wright, E., Hildebrandt, G., Belyakov, O. V., Prise, K. M., & Little, M. P. (2013) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.12.001 · Cited by 229
“MIN is caused by defects in the mismatch repair (MMR) mechanism, which contributes to replication fidelity by correcting incorrectly inserted DNA bases [48].”
BackgroundQian, D. Z., Wang, X., Kachhap, S. K., Kato, Y., Wei, Y., Zhang, L., Atadja, P., & Pili, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0540 · Cited by 229
Jover, R., Zapater, P., Castells, A., Llor, X., Andreu, M., Cubiella, J., Piñol, V, Xicola, R. M., Bujanda, L., Reñé, J. M., et al. (2006) · Gut · doi:10.1136/gut.2005.073015 · Cited by 228
Somatic mutation and gain of copy number of PIK3CA in human breast cancer
Wu, G., Xing, M., Mambo, E., Huang, X., Liu, J., Guo, Z., Chatterjee, A., Goldenberg, D., Gollin, S. M., Sukumar, S., et al. (2005) · Breast Cancer Research · doi:10.1186/bcr1262 · Cited by 228
“Gene amplification/gain of gene copy is well accepted as a later event in tumor progression [18,19], as is somatic mutation [10].”
BackgroundThe linear process of somatic evolution
Nowak, M. A., Michor, F., & Iwasa, Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2535419100 · Cited by 227
Mechanisms underlying losses of heterozygosity in human colorectal cancers
Thiagalingam, S., Laken, S., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051625398 · Cited by 228
Links between mutant p53 and genomic instability
Hanel, W., & Moll, U. M. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23400 · Cited by 216
“There are four types of genomic instability (IN): subtle sequence instabilities at the nucleotide (NIN) and mismatch (MIN) level, chromosomal instability (CIN), and amplification instability (AIN) [Lengauer et al., 1998].”
BackgroundInfluentialAneuploidy and Confined Chromosomal Mosaicism in the Developing Human Brain
Yurov, Y. B., Iourov, I. Y., Vorsanova, S. G., Liehr, T., Kolotii, A. D., Kutsev, S. I., Pellestor, F., Beresheva, A. K., Demidova, I. A., Kravets, V. S., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000558 · Cited by 226
“virtually all cancers [6–8].”
On the role of aurora-A in centrosome function
Dutertre, S., Descamps, S., & Prigent, C. (2002) · Oncogene · doi:10.1038/sj.onc.1205775 · Cited by 226
“The more frequent genomic damage that occurs during cancer development is chromosomal instability that involves gains and losses of pieces of chromosomes or whole chromosomes (Lengauer et al., 1998).”
BackgroundTelomere dysfunction and the initiation of genome instability
Feldser, D. M., Hackett, J. A., & Greider, C. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1142 · Cited by 225
Shu, Y., Wu, X., Tong, X., Wang, X., Chang, Z., Mao, Y., Chen, X., Sun, J., Wang, Z., Hong, Z., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00520-1 · Cited by 223
“Although these techniques are highly sensitive, their two major drawbacks are (1) low throughput on mutation scanning, and (2) the requisite of predefined knowledge of molecular targets to test for, meaning these techniques cannot be used for de novo mutation identification.”
BackgroundTighe, A., Johnson, V. L., & Taylor, S. S. (2004) · Journal of Cell Science · doi:10.1242/jcs.01556 · Cited by 222
“Approximately 85% are aneuploid because of an underlying chromosome instability (Lengauer et al., 1998).”
BackgroundWood, B. R. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00511f · Cited by 219
Radiation-induced genomic instability and its implications for radiation carcinogenesis
Huang, L., Snyder, A. R., & Morgan, W. F. (2003) · Oncogene · doi:10.1038/sj.onc.1206697 · Cited by 219
“Genomic instability in cancer The loss of stability of the genome is now widely accepted as one of the most important aspects of cancer (Lengauer et al., 1998; Coleman and Tsongalis, 1999).”
BackgroundNewcastle disease virus (NDV): brief history of its oncolytic strains
Sinkovics, J. G., & Horvath, J. C. (2000) · Journal of Clinical Virology · doi:10.1016/s1386-6532(99)00072-4 · Cited by 219
“Whatever was the initiating agent (physical, chemical or biological), most human tumors are caused by sequential genetic mutations, mutated gene amplifications, genetic translocations leading to the formation of fusion oncoproteins; preservation of telomeres; and by the loss of tumor suppressor genes (Lengauer et al.,…”
BackgroundParkin as a tumor suppressor gene for hepatocellular carcinoma
Fujiwara, M., Marusawa, H., Wang, H.-Q., Iwai, A., Ikeuchi, K., Imai, Y., Kataoka, A., Nukina, N., Takahashi, R., & Chiba, T. (2008) · Oncogene · doi:10.1038/onc.2008.199 · Cited by 218
“Human cancer develops through a multistep process involving the accumulation of genetic alterations that drive the progression of normal cells into malignant derivatives (Lengauer et al., 1998).”
BackgroundDNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms
Feinberg, A. P., Cui, H., & Ohlsson, R. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00059-7 · Cited by 220
The Consequences of Chromosome Segregation Errors in Mitosis and Meiosis
Potapova, T., & Gorbsky, G. (2017) · Biology · doi:10.3390/biology6010012 · Cited by 213
“In general, most cancers display various degrees of genomic instability, including point mutations, chromosomal rearrangements, and changes in whole chromosome ploidy [62].”
BackgroundIzuta, H., Ikeno, M., Suzuki, N., Tomonaga, T., Nozaki, N., Obuse, C., Kisu, Y., Goshima, N., Nomura, F., Nomura, N., et al. (2006) · Genes to Cells · doi:10.1111/j.1365-2443.2006.00969.x · Cited by 216
Endometriosis and the neoplastic process
Varma, R., Rollason, T., Gupta, J. K., & Maher, E. R. (2004) · Reproduction · doi:10.1530/rep.1.00020 · Cited by 214
“The classic model of malignant transformation of the cell involves the stepwise acquisition of multiple genetic alterations, which confers a clonal selective advantage at each step, predisposing to the next step (Lengauer et al. 1998).”
BackgroundCharacterization of MAD2B and Other Mitotic Spindle Checkpoint Genes
Cahill, D. P., da Costa, L. T., Carson-Walter, E. B., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (1999) · Genomics · doi:10.1006/geno.1999.5831 · Cited by 212
Self-citationDifferent mechanisms in the tumorigenesis of proximal and distal colon cancers
Lindblom, A. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200101000-00013 · Cited by 212
An analysis of genetic heterogeneity in untreated cancers
Reiter, J. G., Baretti, M., Gerold, J. M., Makohon-Moore, A. P., Daud, A., Iacobuzio-Donahue, C. A., Azad, N. S., Kinzler, K. W., Nowak, M. A., & Vogelstein, B. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0185-x · Cited by 209
Telomere length and the risk of lung cancer
Jang, J. S., Choi, Y. Y., Lee, W. K., Choi, J. E., Cha, S. I., Kim, Y. J., Kim, C. H., Kam, S., Jung, T. H., & Park, J. Y. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00831.x · Cited by 210
Current Perspectives in Cancer Immunotherapy
Christofi, T., Baritaki, S., Falzone, L., Libra, M., & Zaravinos, A. (2019) · Cancers · doi:10.3390/cancers11101472 · Cited by 210
Nakao, K. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh134 · Cited by 210
“Colorectal cancers can be classified by the type of genomic instability observed, with over 85% of colorectal cancers demonstrating gross chromosomal aberrations, and 10-- 15% of tumors demonstrating microsatellite instability (3, 4 ).”
BackgroundMolecular biology of lung cancer: Clinical implications
Fong, K. M., & Minna, J. D. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00062-5 · Cited by 209
Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside
Lizardo, D. Y., Kuang, C., Hao, S., Yu, J., Huang, Y., & Zhang, L. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188447 · Cited by 205
“Most (~85%) CRCs are proficient in MMR (pMMR) and have CIN phenotypes such as abnormalities in chromosomal number and structure [15].”
BackgroundTopoisomerase IIα in chromosome instability and personalized cancer therapy
Chen, T., Sun, Y., Ji, P., Kopetz, S., & Zhang, W. (2015) · Oncogene · doi:10.1038/onc.2014.332 · Cited by 207
Dicker, F., Herholz, H., Schnittger, S., Nakao, A., Patten, N., Wu, L., Kern, W., Haferlach, T., & Haferlach, C. (2009) · Leukemia · doi:10.1038/leu.2008.274 · Cited by 208
Dwight, T., Thoppe, S. R., Foukakis, T., Lui, W. O., Wallin, G., Höög, A., Frisk, T., Larsson, C., & Zedenius, J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021690 · Cited by 208
“Translocations or inversions can give rise to the activation of an oncogene through its positioning near a strong promoter or its fusion with another gene, endowing the fused transcript with tumorigenic properties (4).”
BackgroundHistone levels are regulated by phosphorylation and ubiquitylation-dependent proteolysis
Singh, R. K., Kabbaj, M.-H. M., Paik, J., & Gunjan, A. (2009) · Nature Cell Biology · doi:10.1038/ncb1903 · Cited by 205
“Genomic instability is characterized by the acquisition of genome alterations and is associated with human cancer”
BackgroundPrinciple and applications of digital PCR
Pohl, G., & Shih, I.-M. (2004) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.4.1.41 · Cited by 206
Cancer: Evolution Within a Lifetime
Gerlinger, M., McGranahan, N., Dewhurst, S. M., Burrell, R. A., Tomlinson, I., & Swanton, C. (2014) · Annual Review of Genetics · doi:10.1146/annurev-genet-120213-092314 · Cited by 205
Budanov, A. V. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3530 · Cited by 200
“DNA damage can cause mutagenesis and genomic instability, important features of carcinogenesis (72).”
BackgroundDNA methylation in breast cancer.
Yang, X., Yan, L., & Davidson, N. E. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080115 · Cited by 204
The gastrointestinal microbiota and colorectal cancer
Keku, T. O., Dulal, S., Deveaux, A., Jovov, B., & Han, X. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00360.2012 · Cited by 205
“The first model depicting key genetic alterations in CRC included the activation of K-ras oncogene (44, 84, 163) and the inactivation of tumor suppressor genes such as adenomatous polyposis coli (104, 133) and p53 (encoded by TP53 gene in human) (164, 169).”
BackgroundThe detection and implication of genome instability in cancer
Pikor, L., Thu, K., Vucic, E., & Lam, W. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9429-5 · Cited by 203
“Although both types of instability appear to occur early in tumor development and increase with tumor progression, cancers with an MMR deficiency tend to be diploid and exhibit normal rates of gross chromosomal changes, whereas MMR-proficient tumors are typically aneuploid and display increased rates of chromosomal al…”
Cell-to-cell fusion as a link between viruses and cancer
Duelli, D., & Lazebnik, Y. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2272 · Cited by 204
DNA mismatch repair genes and colorectal cancer
WHEELER, J. M. D., BODMER, W. F., WHEELER, J. M. D., & MORTENSEN, N. J. M. (2000) · Gut · doi:10.1136/gut.47.1.148 · Cited by 201
Epigenetic inactivation of CHFR in human tumors
Toyota, M., Sasaki, Y., Satoh, A., Ogi, K., Kikuchi, T., Suzuki, H., Mita, H., Tanaka, N., Itoh, F., Issa, J.-P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1337066100 · Cited by 199
Pestell, R. G. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.03.001 · Cited by 197
The molecular genetics of cervical carcinoma
Lazo, P. A. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690635 · Cited by 198
“Cancer is a multigenic disease, mostly somatic (Kinzler Vogelstein, 1996, 1998; Lengauer et al, 1998).”
The two sides of chromosomal instability: drivers and brakes in cancer
Hosea, R., Hillary, S., Naqvi, S., Wu, S., & Kasim, V. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01767-7 · Cited by 189
“45,47 In 1997, Lengauer et al. quanti fi ed CIN in human cancer cell lines, proposing its universality across cancers; 49,50 while Angelika Amon ’ s works from 1999 until 2010 elucidated the molecular aspects of checkpoint crucial in CIN.”
BackgroundEpithelial Cell Plasticity in Development and Tumor Progression
Thiery, J. P., & Chopin, D. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006256219004 · Cited by 197
“A large set of genes may be involved in the chromosome number instabilities and chromosome translocations that result in multiple gains and losses [1], thereby constituting a major obstacle to the discovery of novel prognostic indicators.”
BackgroundDeregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation
Mailand, N., Lukas, C., Kaiser, B. K., Jackson, P. K., Bartek, J., & Lukas, J. (2002) · Nature Cell Biology · doi:10.1038/ncb777 · Cited by 195
Mutation–selection networks of cancer initiation: tumor suppressor genes and chromosomal instability
Komarova, N. L., Sengupta, A., & Nowak, M. A. (2003) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(03)00120-6 · Cited by 194
“There has been a long standing debate whether the somatic evolution of cancer requires cancer cells to have genetic instability (Loeb, 1998; Lengauer et al., 1998; Schmutte and Fishel, 1999; Strauss, 1998).”
BackgroundTPX2: of spindle assembly, DNA damage response, and cancer
Neumayer, G., Belzil, C., Gruss, O. J., & Nguyen, M. D. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1582-7 · Cited by 193
Maley, C. C., Galipeau, P. C., Li, X., Sanchez, C. A., Paulson, T. G., Blount, P. L., & Reid, B. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1738 · Cited by 193
Spindle orientation, asymmetric division and tumour suppression in Drosophila stem cells
Gonzalez, C. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2103 · Cited by 193
“Genome instability, which can be recognized as cytologically abnormal karyotypes including chromosomal rearrangements and variable chromosome numbers, is a frequent trait in many cancer”
BackgroundThe Centrosomal Kinase Nek2 Displays Elevated Levels of Protein Expression in Human Breast Cancer
Hayward, D. G., Clarke, R. B., Faragher, A. J., Pillai, M. R., Hagan, I. M., & Fry, A. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0960 · Cited by 192
“Ominously, chromosome instability leads to a heterogenous population of cells with respect to genetic content and provides the tumor with a mechanism to select for cells with more malignant or drug resistant properties (4).”
BackgroundHuman securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis
Bernal, J. A., Luna, R., Espina, Á., Lázaro, I., Ramos-Morales, F., Romero, F., Arias, C., Silva, A., Tortolero, M., & Pintor-Toro, J. A. (2002) · Nature Genetics · doi:10.1038/ng997 · Cited by 193
Ching, Y.-P., Wong, C.-M., Chan, S.-F., Leung, T. H.-Y., Ng, D. C.-H., Jin, D.-Y., & Ng, I. O.-L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208310200 · Cited by 192
Carcinogenicity of hexavalent chromium.
Holmes, A. L., Wise, J. P., & Wise, J. P. (2008) · PubMed · Cited by 192
Douglas, E. J., Fiegler, H., Rowan, A., Halford, S., Bicknell, D. C., Bodmer, W., Tomlinson, I. P. M., & Carter, N. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0328 · Cited by 192
“CRCs can be categorized according to the type of genomic instability that they are thought to exhibit, namely chromosomal instability (CIN), characterized by an aneuploid/polyploid karyotype (6, 7) or microsatellite instability (MSI), characterized by defective mismatch repair and a near-diploid karyotype (8, 9).”
BackgroundGenome-wide detection of chromosomal imbalances in tumors using BAC microarrays
Cai, W.-W., Mao, J.-H., Chow, C.-W., Damani, S., Balmain, A., & Bradley, A. (2002) · Nature Biotechnology · doi:10.1038/nbt0402-393 · Cited by 191
All y’all need to know ‘bout retroelements in cancer
Belancio, V. P., Roy-Engel, A. M., & Deininger, P. L. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.06.001 · Cited by 188
“Genetic instability is one of the key features associated with cancer causation and progression [1–5].”
Three Classes of Genes Mutated In Colorectal Cancers with Chromosomal Instability
Wang, Z., Cummins, J. M., Shen, D., Cahill, D. P., Jallepalli, P. V., Wang, T.-L., Parsons, D. W., Traverso, G., Awad, M., Silliman, N., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0587 · Cited by 189
“tulated to be responsible for CIN (3, 4).”
Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities
Wang, W., Kandimalla, R., Huang, H., Zhu, L., Li, Y., Gao, F., Goel, A., & Wang, X. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.05.002 · Cited by 187
“Majority of CRC patients exhibit CIN (65–85%) [13,14], and are typically characterized to possess a ‘classical’ or ‘canonical’ type of cancer.”
BackgroundEmerging trends in colorectal cancer: Dysregulated signaling pathways (Review)
Ahmad, R., Singh, J., Wunnava, A., Al‑Obeed, O., Abdulla, M., & Srivastava, S. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4847 · Cited by 189
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors
Brummelkamp, T. R., Fabius, A. W. M., Mullenders, J., Madiredjo, M., Velds, A., Kerkhoven, R. M., Bernards, R., & Beijersbergen, R. L. (2006) · Nature Chemical Biology · doi:10.1038/nchembio774 · Cited by 189
“This labels cancer tissues with a feature not seen in normal tissues, and it has therefore been suggested that genetic instability is an Achilles heel of tumor cells that could be exploited by future anticancer therapeutics 27 .”
Upender, M. B., Habermann, J. K., McShane, L. M., Korn, E. L., Barrett, J. C., Difilippantonio, M. J., & Ried, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0474 · Cited by 188
Schoch, C., Kern, W., Kohlmann, A., Hiddemann, W., Schnittger, S., & Haferlach, T. (2005) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20193 · Cited by 188
“yotypes usually show microsatellite instability, whereas complex aberrant cases do not (Lengauer et al., 1998).”
BackgroundInfluentialSelective Cell Death of Hyperploid Neurons in Alzheimer’s Disease
Arendt, T., Brückner, M. K., Mosch, B., & Lösche, A. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090955 · Cited by 186
Can chromosomal instability initiate tumorigenesis?
Michor, F., Iwasa, Y., Vogelstein, B., Lengauer, C., & Nowak, M. A. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.09.007 · Cited by 185
“All rights reserved. eywords:Somatic evolution of cancer; Mathematical model; Chromosomal instability; Tumor suppressor gene inactivation Contents 1.”
BackgroundDNA damage response – A double-edged sword in cancer prevention and cancer therapy
Tian, H., Gao, Z., Li, H., Zhang, B., Wang, G., Zhang, Q., Pei, D., & Zheng, J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.12.038 · Cited by 186
“DNA damage, due to environmental factors or normal metabolic processes inside the cell, can compromise the cell’s ability to carry out its regular function, which is appreciably prone to genomic instability [1–3].”
BackgroundBennecke, M., Kriegl, L., Bajbouj, M., Retzlaff, K., Robine, S., Jung, A., Arkan, M. C., Kirchner, T., & Greten, F. R. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.013 · Cited by 186
“APC mutations lead to chromosomal instability (CIN) and followed by additional mutations in tumor suppressors and oncogenes along the adenoma-carcinoma sequence ultimately to invasive cancer (Lengauer et al., 1998).”
BackgroundTargeted inactivation of p53 in human cells does not result in aneuploidy.
Bunz, F., Fauth, C., Speicher, M. R., Dutriaux, A., Sedivy, J. M., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (2002) · PubMed · Cited by 184
Whole‐exome sequencing of pancreatic neoplasms with acinar differentiation
Jiao, Y., Yonescu, R., Offerhaus, G. J. A., Klimstra, D. S., Maitra, A., Eshleman, J. R., Herman, J. G., Poh, W., Pelosof, L., Wolfgang, C. L., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4310 · Cited by 184
“These data are consistent with the hypothesis that these tumours are chromosomally unstable, though instability is a rate rather than a state and cannot be measured through evaluation of tumours at a single point in time [28].”
ResultOral Cancer Prevention and the Evolution of Molecular-Targeted Drug Development
Lippman, S. M., Sudbø, J., & Hong, W. K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.128 · Cited by 185
Tejpar, S., Bertagnolli, M., Bosman, F., Lenz, H.-J., Garraway, L., Waldman, F., Warren, R., Bild, A., Collins-Brennan, D., Hahn, H., et al. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0233 · Cited by 185
Fraschini, R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6648 · Cited by 185
Evolution of the cancer genome
Podlaha, O., Riester, M., De, S., & Michor, F. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.01.003 · Cited by 188
Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer
Leek, R. D., Hunt, N. C., Landers, R. J., Lewis, C. E., Royds, J. A., & Harris, A. L. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200003)190:4<430::aid-path538>3.0.co;2-6 · Cited by 322
Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution
Heng, H. H., Bremer, S. W., Stevens, J. B., Horne, S. D., Liu, G., Abdallah, B. Y., Ye, K. J., & Ye, C. J. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9427-7 · Cited by 184
“Though there were some established molecular mechanisms of genomic instability [32], it was Vogelstein’s group who highlighted this issue by classifying genetic instability into CIN and micro-satellite instability, reinforcing the idea that most colon cancers are indeed chromosomally unstable [33].”
BackgroundEndogenous DNA damage and mutation
Marnett, L. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02239-9 · Cited by 183
Huang, S. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9435-7 · Cited by 182
“The term “genetic instability” (or, more concretely, genomic instability when emphasizing its material substrate) is used to refer to the simple observation that cancer cells are defective in the fidelity of replicating DNA and its proper partitioning to the daughter cells during cell division—be it at the level of si…”
Simon, J. A., Szankasi, P., Nguyen, D. K., Ludlow, C. L., Dunstan, H. M., Roberts, C. J., Jensen, E. L., Hartwell, L. H., & Friend, S. H. (2000) · PubMed · Cited by 193
Chang, S., Khoo, C. M., Naylor, M. L., Maser, R. S., & DePinho, R. A. (2003) · Genes & Development · doi:10.1101/gad.1029903 · Cited by 183
“These two classes have been operationally defined as “microsatellite instability neoplasias” and “chromosomal instability neoplasias” (MIN and CIN), respectively (for review, see Lengauer et al. 1998).”
BackgroundCathepsin L, target in cancer treatment?
Lankelma, J. M., Voorend, D. M., Barwari, T., Koetsveld, J., Van der Spek, A. H., De Porto, A. P. N. A., Van Rooijen, G., & Van Noorden, C. J. F. (2010) · Life Sciences · doi:10.1016/j.lfs.2009.11.016 · Cited by 180
Gius, D., Cui, H., Bradbury, C. M., Cook, J., Smart, D. K., Zhao, S., Young, L., Brandenburg, S. A., Hu, Y., Bisht, K. S., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.029 · Cited by 181
Karakaidos, P., Taraviras, S., Vassiliou, L. V., Zacharatos, P., Kastrinakis, N. G., Kougiou, D., Kouloukoussa, M., Nishitani, H., Papavassiliou, A. G., Lygerou, Z., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63393-7 · Cited by 180
Fujisawa, H., Reis, R. M., Nakamura, M., Colella, S., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780009 · Cited by 180
“…little is known about the mechanisms of chromosomal deletion, except for the general assumption that it is probably attributed to chromosomal instability caused by the disruption of mitotic checkpoints (Lengauer et al, 1998) or premature mitosis involving damaged DNA (Paulovich et al, 1997).”
BackgroundGenetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis
Fearnhead, N. S., Wilding, J. L., & Bodmer, W. F. (2002) · British Medical Bulletin · doi:10.1093/bmb/64.1.27 · Cited by 179
Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells
Koniaras, K., Cuddihy, A. R., Christopoulos, H., Hogg, A., & O'Connell, M. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204942 · Cited by 176
“In contrast to the ®delity of normal cell division, cancer cells exhibit a high degree of genomic instability, widely thought to promote a heightened rate of mutation, allowing cancer cells to evolve (Lengauer et al., 1998).”
BackgroundColorectal cancer: a model for epigenetic tumorigenesis
Wong, J. J. L., Hawkins, N. J., & Ward, R. L. (2007) · Gut · doi:10.1136/gut.2005.088799 · Cited by 178
Genome-Wide Appraisal of Thyroid Cancer Progression
Wreesmann, V. B., Ghossein, R. A., Patel, S. G., Harris, C. P., Schnaser, E. A., Shaha, A. R., Tuttle, R. M., Shah, J. P., Rao, P. H., & Singh, B. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64433-1 · Cited by 178
p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination.
Linke, S. P., Sengupta, S., Khabie, N., Jeffries, B. A., Buchhop, S., Miska, S., Henning, W., Pedeux, R., Wang, X. W., Hofseth, L. J., et al. (2003) · PubMed · Cited by 227
Valverde, J. R., Alonso, J., Palacios, I., & Pestaña, Á. (2005) · BMC Genetics · doi:10.1186/1471-2156-6-53 · Cited by 177
“mismatch repair (MSH2–MSH6) activities [26].”
Aneuploid neurons are functionally active and integrated into brain circuitry
Kingsbury, M. A., Friedman, B., McConnell, M. J., Rehen, S. K., Yang, A. H., Kaushal, D., & Chun, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408171102 · Cited by 177
Middeldorp, J. M., Brink, A. A. T. P., van den Brule, A. J. C., & Meijer, C. J. L. M. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00078-1 · Cited by 178
“[23] Lengauer C, Kinzler KW, Vogelstein B.”
BackgroundSpontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells
Zhou, Y. F., Bosch-Marce, M., Okuyama, H., Krishnamachary, B., Kimura, H., Zhang, L., Huso, D. L., & Semenza, G. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2146 · Cited by 177
Prevalence of somatic alterations in the colorectal cancer cell genome
Wang, T.-L., Rago, C., Silliman, N., Ptak, J., Markowitz, S., Willson, J. K. V., Parmigiani, G., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261714699 · Cited by 177
Telomeres and chromosome instability
Murnane, J. P. (2006) · DNA Repair · doi:10.1016/j.dnarep.2006.05.030 · Cited by 175
Fukagawa, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.16.4603 · Cited by 175
Early aging–associated phenotypes in Bub3/Rae1 haploinsufficient mice
Baker, D. J., Jeganathan, K. B., Malureanu, L., Perez-Terzic, C., Terzic, A., & van Deursen, J. M. A. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200507081 · Cited by 175
“Because aneuploidy occurs with such high frequency, it has been suggested that an euploidy is an essential step in the process of tumorigenesis (Lengauer et al., 1998).”
BackgroundKennedy, R. D., Chen, C. C., Stuckert, P., Archila, E. M., De la Vega, M. A., Moreau, L. A., Shimamura, A., & D’Andrea, A. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31245 · Cited by 175
“Introduction Genomic instability is an important feature in cancer progression, as it enables the activation of oncogenes, inactivation of tumor suppressor genes, and amplification of treatment-resistance genes (1, 2).”
Background
Metadata
- Authors
- Lengauer, C., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1998-12
- Volume
- 396
- Issue
- 6712
- Pages
- 643-649
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1544851750
- Cited by
- 4,168
- References
- 98
- Citations by year
- 2026: 18 · 2025: 44 · 2024: 56 · 2023: 74 · 2022: 83 · 2021: 91 · 2020: 92 · 2019: 90 · 2018: 99 · 2017: 106 · 2016: 113 · 2015: 136 · 2014: 145 · 2013: 156 · 2012: 183
- FWCI
- 15.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- genomic instability, carcinogenesis, chromosomal instability, microsatellite instability, base substitutions, chromosomal deletion, chromosomal gains, cancer genetics
- MeSH terms
- Chromosome Aberrations, Gene Amplification, Humans, Neoplasms, Translocation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.